Articles by Gary Walsh, PhD - BioPharm International



Articles by Gary Walsh, PhD

Gary Walsh, PhD

Associate Professor in the Industrial Biochemistry Program at the University of Limerick. He is also a member of BioPharm International's Editorial Advisory Board.

Biopharmaceuticals Approval Trends in 2013
April 1, 2014

A review of the past year's trends in biopharmaceutical approvals shows an above average approval rate.

Milestones and Moderate Progress in 2012 Drug Approvals
April 1, 2013

First gene therapy and plant-based expression vector products approved in 2012.

New Biopharmaceuticals
June 1, 2012

A review of new biologic drug approvals over the years, featuring highlights from 2010 and 2011.

Biopharmacetiucal Approval Trends in 2009
October 1, 2010

Biotech approvals were up last year. Is it a sign of a new trend?

Biopharmaceuticals: Approval Trends in 2008
October 1, 2009

Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.

Biopharmaceuticals: Approval Trends in 2007
October 1, 2008

The year 2007 witnessed the approval of fifteen biopharmaceuticals in the United States and European Union.

Book Review: Biopharmaceutical Products in the US and European Markets 6th edition (2 volumes)
April 1, 2008

The book is a useful, comprehensive, and truly an excellent reference source of biopharmaceutical information.

Engineering Biopharmaceuticals
November 1, 2007

An overall increasing proportion of future product approvals will be engineered in some way, either directly or indirectly.

Biopharmecuticals: Approval Trends in 2006
September 1, 2007

There were notable approvals in nonparenteral delivery systems and biosimiliars in 2006.



Click here